HSBC Holdings
IMVT icon

HSBC Holdings’s Immunovant IMVT Stock Holding History

HSBC Holdings’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-31,896
Closed -$780K – 3149
2024
Q4 		$780K Buy
+31,896
New +$905K ﹤0.01% 1935
2024
Q2 		– Sell
-7,298
Closed -$236K – 3051
2024
Q1 		$236K Buy
+7,298
New +$266K ﹤0.01% 2589
2023
Q1 		– Sell
-49,592
Closed -$862K – 2840
2022
Q4 		$862K Sell
49,592
-79,697
-62% -$1M ﹤0.01% 2048
2022
Q3 		$712K Buy
129,289
+6,869
+6% +$33.6K ﹤0.01% 1999
2022
Q2 		$486K Buy
122,420
+12,481
+11% +$53.9K ﹤0.01% 2350
2022
Q1 		$615K Buy
109,939
+4,866
+5% +$30.3K ﹤0.01% 2261
2021
Q4 		$909K Buy
105,073
+47,785
+83% +$394K ﹤0.01% 2107
2021
Q3 		$510K Buy
+57,288
New +$517K ﹤0.01% 2240
2021
Q1 		– Sell
-7,899
Closed -$366K – 2924
2020
Q4 		$366K Sell
7,899
-5,221
-40% -$241K ﹤0.01% 2428
2020
Q3 		$481K Sell
13,120
-12,153
-48% -$366K ﹤0.01% 1967
2020
Q2 		$615K Sell
25,273
-3,469
-12% -$74.3K ﹤0.01% 1703
2020
Q1 		$447K Buy
+28,742
New +$432K ﹤0.01% 1835

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

HSBC Holdings's IMVT Position: Q1 2025 in Review

HSBC Holdings sold out of Immunovant (IMVT) in Q1 2025, closing a stake of 31,896 shares — an estimated $780K sold.

HSBC Holdings first reported a position in IMVT in Q1 2020 and held it in 12 quarters. The position peaked at $909K in Q4 2021. 193 funds tracked by Wall St. Rank hold IMVT as of Q1 2025.

  • HSBC Holdings reported no remaining Immunovant position as of Q1 2025 after selling out during the quarter.
  • HSBC Holdings sold 31,896 Immunovant shares in Q1 2025, an estimated $780K.
  • HSBC Holdings first reported a position in Immunovant in Q1 2020 and held it in 12 quarters.
  • HSBC Holdings's Immunovant position peaked at $909K in Q4 2021.
  • 193 funds tracked by Wall St. Rank held Immunovant as of Q1 2025.

Based on HSBC Holdings's 13F filing for Q1 2025, filed 14 May 2025.